Latest stories on LENZ
Millennium Management LLC Trims LENZ Therapeutics Inc (LENZ) Stake by 23.10%
GuruFocus38 · neutralgeneral
LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
GlobeNewswire50 · neutralgeneral
LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
Business Insider50 · neutralgeneral
Lenz Therapeutics price target lowered to $5 from $7 at Piper Sandler
The Fly34 · bearishanalyst
LENZ investor alert spotlights VIZZ’s flat $1.73M product sales and a Bank of America downgrade
October 7, 2026
MarketChameleon38 · neutralgeneral
LENZ Therapeutics: Below Cash For A Reason
Seeking Alpha28 · bearishgeneral
LENZ Therapeutics: Still Speculative But Priced For Disasters
Seeking Alpha64 · neutralanalyst
LENZ Therapeutics (LENZ) Q2 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
LENZ Therapeutics (LENZ) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Lenz Therapeutics reports Q2 EPS ($1.02), consensus ($1.07)
The Fly34 · bearishearnings
Lenz Therapeutics downgraded to Neutral from Buy at BofA
The Fly48 · neutralanalyst
Lenz drops as BofA downgrades on a slower VIZZ launch
Seeking Alpha42 · neutralanalyst
BofA downgrades Lenz Therapeutics stock rating on slow launch
Investing.com Analyst Ratings34 · bearishanalyst
LENZ Delivers Robust Q2 Revenue Growth—Prescriber Uptake and Global Expansion Signal Momentum for VIZZ
August 12, 2026
MarketChameleon73 · bullishearnings
Why is LENZ Therapeutics stock rallying today?
Investing.com Markets50 · neutralgeneral
Lenz outlines July telehealth and national TV push as VIZZ scripts rise over 45% month over month
Seeking Alpha63 · neutralproduct/pr
LENZ Therapeutics, Inc. (LENZ) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
LENZ Therapeutics, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
LENZ Therapeutics Q2 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
LENZ Therapeutics GAAP EPS of -$1.02 beats by $0.04, revenue of $5.5M beats by $3.12M
Seeking Alpha63 · neutralearnings
LENZ Therapeutics, Inc. (LENZ) files 8-K
SEC 8-K50 · neutralgeneral
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Business Insider55 · neutralearnings
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire56 · neutralearnings
LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
StockTitan50 · neutralgeneral